MedTrace Logo

Implementation for Heart Failure Therapies Post-discharge Followed by CardiOSIgnal at HOME

NCT06944405 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2025-04-25

No results posted yet for this study

Summary

CardioSignal technology (mechanocardiography) could enable home follow-up after admission for acute heart failure, thus improving guidline-directed medical therapies for heart failure dose escalation while reducing the logistical constraints and stress associated with frequent hospital visits. The intended purpose is to detect signs of HF in adults (aged 18 years or older and \< 85 years)

Conditions

Interventions

DEVICE

Mechanocardiography

Using mechanocardiography for the detection of signs of heart failure.

Sponsors & Collaborators

  • Eshmoun Clinical Research Center

    collaborator NETWORK

  • Sahloul Hospital of Sousse

    collaborator OTHER

  • Precordior Ltd

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-10
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06944405 on ClinicalTrials.gov